secwatch / observer
8-K filed November 21, 2022, 6:59 PM ET ticker HCTI CIK 0001839285
other material confidence high sentiment neutral materiality 0.55

Healthcare Triangle shareholders approve reverse stock split and evergreen share plan amendment

Healthcare Triangle, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Healthcare Triangle, Inc. shareholders approved Approval of an amendment to the restated certificate of incorporation to effect a reverse stock split at the 2022-11-17 meeting.

Proposal
reverse split
Outcome
passed
Meeting
2022-11-17
Exact text from the filing
Proposal No. 2: Approval of an Amendment to the Amended and Restated Certificate of Incorporation to Effect the Reverse Stock Split The Company’s shareholders approved the resolution to give the Board of Directors (“Board”) the discretion to effect the Reverse Stock Split (as defined in the Proxy Statement) of the Company’s common stock in a range of split ratios from 1-for-2 to 1-for-10 at any time prior to May 29, 2023. The table below sets forth the voting results for Proposal 2:
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Healthcare Triangle, Inc. shareholders approved Proposal to amend the 2020 stock incentive plan to provide for automatic increases in the number of shares subject to the plan at the 2022-11-17 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2022-11-17
Exact text from the filing
Proposal No. 3: Proposal to Amend the 2020 Stock Incentive Plan to Provide for Automatic Increases in the Number of Shares Subject to the Plan The Company’s shareholders approved the resolution to amend (the “Plan Amendment”) the Healthcare Triangle, Inc. 2020 Stock Incentive Plan (“Plan”) to provide for the automatic increase in the number of shares under the Plan on the first day of each fiscal year beginning with the 2023 fiscal year, in an amount equal to the least of: (a) 2,000,000 shares, (b) a number of shares equal to eight percent (8%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (c) such number of shares determined by the Administrator of the Plan no later than the last day of the immediately preceding fiscal year. The Plan Amendment will terminate with the termination of the Plan on December 31, 2030. The table below sets forth the voting results for Proposal 3:
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Healthcare Triangle, Inc. shareholders approved Ratification of appointment of Ram Associates CPAS as independent registered public accounting firm for fiscal year ending December 31, 2022 at the 2022-11-17 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2022-11-17
Exact text from the filing
Proposal No. 4: Ratification of the Auditors The Company’s shareholders approved the resolution to approve Ram Associates CPAS as the Company’s independent public accounting firm for fiscal 2022. The table below sets forth the voting results for Proposal 4:
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Healthcare Triangle, Inc. shareholders approved Election of seven directors to serve a one-year term at the 2022-11-17 meeting.

Proposal
director election
Outcome
passed
Meeting
2022-11-17
Exact text from the filing
Proposal No. 1: Election of Directors The Company’s shareholders elected all of the director nominees nominated by the Board to serve for a one-year term, until the 2023 annual meeting of shareholders and until their successors are duly elected and qualified. The table below sets forth the voting results for Proposal 1:
View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Healthcare Triangle, Inc. filing history →

Source: SEC EDGAR
accession 0001607062-22-000718
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.